mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)

Shernan G. Holtan; Luis F. Porrata; Joseph P. Colgan; Clive S. Zent; Thomas M. Habermann; Svetomir N. Markovic

doi:10.1002/ajh.21216

mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)

Shernan G. Holtan, Luis F. Porrata, Joseph P. Colgan, Clive S. Zent, Thomas M. Habermann, Svetomir N. Markovic

Hematology

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	688-689
Number of pages	2
Journal	American journal of hematology
Volume	83
Issue number	8
DOIs	https://doi.org/10.1002/ajh.21216
State	Published - Aug 2008

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.21216

Cite this

@article{9ea07fd9c3554deea62839ec16e66462,

title = "mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)",

author = "Holtan, {Shernan G.} and Porrata, {Luis F.} and Colgan, {Joseph P.} and Zent, {Clive S.} and Habermann, {Thomas M.} and Markovic, {Svetomir N.}",

year = "2008",

month = aug,

doi = "10.1002/ajh.21216",

language = "English (US)",

volume = "83",

pages = "688--689",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "8",

}

TY - JOUR

T1 - mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)

AU - Holtan, Shernan G.

AU - Porrata, Luis F.

AU - Colgan, Joseph P.

AU - Zent, Clive S.

AU - Habermann, Thomas M.

AU - Markovic, Svetomir N.

PY - 2008/8

Y1 - 2008/8

UR - http://www.scopus.com/inward/record.url?scp=49149087079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49149087079&partnerID=8YFLogxK

U2 - 10.1002/ajh.21216

DO - 10.1002/ajh.21216

M3 - Letter

C2 - 18528858

AN - SCOPUS:49149087079

SN - 0361-8609

VL - 83

SP - 688

EP - 689

JO - American journal of hematology

JF - American journal of hematology

IS - 8

ER -

mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this